Evidence map›Paper›PMID 26471058›Full record

ArticleBMC complementary and alternative medicine2015

Antimalarial activity of 80 % methanolic extract of Brassica nigra (L.) Koch. (Brassicaceae) seeds against Plasmodium berghei infection in mice.

Abrham Belachew Muluye, Eshetie Melese, Getnet Mequanint Adinew

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Overview of Phytochemical Composition ofFoods (Basel, Switzerland) · 2024
    Review
  4. Molecules (Basel, Switzerland) · 2022
    Review
  5. Review
  6. Antimalarial Activity of Crude Extract and Solvent Fractions of Leaves ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  7. Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  8. Evaluation of Antimalarial Activity of 80% Methanolic Root Extract ofClinical pharmacology : advances and applications · 2021
    Article
  9. Journal of tropical medicine · 2021
    Article
  10. Antimalarial Effect of the Root ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  11. Article
  12. Antimalarial Activity ofEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  13. Article
  14. Antiplasmodial activity of two medicinal plants against clinical isolates ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2018
    Article
  15. Antimalarial and cytotoxic activities of roots and fruits fractions ofIranian journal of basic medical sciences · 2017
    Article
  16. Article
  17. THERAPEUTIC POTENTIALS OF ETHANOLIC EXTRACT OF LEAVES OFAfrican journal of traditional, complementary, and alternative medicines : AJTCAM · 2017
    Article
  18. Antimalarial Activity of Seed Extracts ofJournal of evidence-based integrative medicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Abrham Belachew MuluyeDepartment of Pharmacy, Wollega University, Nekemte, Ethiopia.
Eshetie MeleseDepartment of Pharmacology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. meshetie21@gmail.com.
Getnet Mequanint AdinewDepartment of Pharmacology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
University of Gondar · ETWollega University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResistances to currently available drugs and insecticides, significant drug toxicities and costs and lack of vaccines currently complicated the treatment of malaria. A continued search for safe, effective and affordable plant-based antimalarial agents thus becomes crucial and vital in the face of these difficulties. The aim of the study was to evaluate the antimalarial activity of 80 % methanolic extract of the seeds of Brassica nigra against Plasmodium berghei infection in mice.

methodChloroquine sensitive Plasmodium berghei (ANKA strain) was used to test the antimalarial activity of the extract. In suppressive and prophylactic models, Swiss albino male mice were randomly grouped into five groups of five mice each. Group I mice were treated with the vehicle, group II, III and IV were treated with 100, 200, and 400 mg/kg of the extract, respectively and the last group (V) mice were treated with chloroquine (10 mg/kg). The level of parasitemia, survival time and variation in weight of mice were used to determine the antimalarial activity of the extract.

resultsChemosuppressive activities produced by the extract of the seeds of Brassica nigra were 21.88, 50.00 (P < 0.01) and 53.13 % (P < 0.01), while the chemoprophylactic activities were 17.42, 21.21 and 53.79 % (P < 0.05) at 100, 200 and 400 mg/kg of the extract, respectively as compared to the negative control. Mice treated with 200 and 400 mg/kg extract were significantly (P < 0.05) lived longer and gained weight as compared to negative control in 4-day suppressive test.

conclusionFrom this study, it can be concluded that the seed extract of Brassica nigra showed good chemosuppressive and moderate chemoprophylactic activities and the plant may contain biologically active principles which are relevant in the treatment and prophylaxis of malaria, thus supporting further studies of the plant for its active components.

Indexed as

PhytotherapyAnimalsAntimalarialsDose-Response Relationship, DrugMalariaMaleMethanolMiceMustard PlantParasitemiaPlant ExtractsPlasmodium bergheiSeedsAntimalarialsMethanolPlant Extracts

Identifiers

PMID26471058
PMCPMC4608310
OpenAlexW1854459364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.